If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRENE.L Regulatory News (RENE)

  • There is currently no data for RENE

Block Listing Six Monthly Review

17 Mar 2014 11:00

RNS Number : 4527C
ReNeuron Group plc
17 March 2014
 



 

 

 

17 March 2014

AIM: RENE

ReNeuron Group plc

 

Block Listing Six Monthly Review

 

 

 

Name:

ReNeuron Group plc

Name of Scheme:

Share-based payment agreements

Period of Return:

From 1 June 2011 to 14 March 2014

Balance of unalloted securities under scheme(s) from previous return:

1,645,786

 

Plus: The amount by which the block scheme(s) has been increased since the date of the last Review (if any increase has been applied for):

N/A

Less: Number of securities issued/allotted under scheme(s) during period

 

nil

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

1,645,786

 

Number and class of securities originally admitted:

2,000,000 ordinary shares of 1p each

Date of original admission:

13 May 2010

 

 

 

Enquiries:

ReNeuron Group plc

Michael Hunt, Chief Executive Officer

Tel: + 44 (0) 1483 302 560

Cenkos

Stephen Keys, Dr Christopher Golden (NOMAD and Broker)

Tel: + 44 (0) 207 397 8900

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRJRMMTMBMBBMI
Date   Source Headline
2nd Sep 20247:00 amRNSCancellation - ReNeuron Group Plc
30th Aug 20247:00 amRNSCorporate update and AIM cancellation
2nd Aug 202412:25 pmRNSCorporate Update
26th Jun 20243:33 pmRNSChange of Registered Address
5th Jun 20243:36 pmRNSCreditor’s decision on Administrators' Proposals
17th May 202412:45 pmRNSPublication of Joint Administrators' Proposals
8th May 20247:00 amRNSUpdate on Administration Process
17th Apr 202411:30 amRNSDirectorate Change
20th Mar 20243:43 pmRNSAppointment of Administrators
20th Mar 202412:30 pmRNSIntention to Appoint Administrators
1st Mar 20247:00 amRNSBlock Listing Review & Total Voting Rights
5th Feb 20242:30 pmRNSSuspension - ReNeuron Group plc
5th Feb 20242:30 pmRNSCorporate update and suspension of trading on AIM
27th Nov 20238:53 amEQSEdison issues update on ReNeuron Group (RENE): H124 results reaffirm focus on CustomEX™
8th Nov 20237:01 amRNSInterim Results for the six months ended 30 Sept
8th Nov 20237:00 amRNSReNeuron presents in vivo data at Cell 2023
4th Sep 20237:00 amRNSR&D Update
1st Sep 20237:00 amRNSBlock Listing Review & Total Voting Rights
29th Aug 20237:00 amRNSDirector declaration
22nd Aug 202310:34 amRNSResult of AGM
24th Jul 20235:20 pmRNSNotice of AGM
12th Jul 202311:57 amRNSShare Purchase by Chief Financial Officer
16th Jun 20235:12 pmRNSShare Purchase by Senior Independent NED
16th Jun 20232:26 pmRNSShare Purchase by Executive Chairman
16th Jun 20237:00 amRNSPosting of Annual Report & Accounts
5th Jun 20234:30 pmRNSHolding(s) in Company
25th May 20237:00 amRNSUnaudited Preliminary Results
18th May 20237:00 amRNSNotice of Results
17th May 20238:56 amRNSHolding(s) in Company
27th Apr 20238:18 amRNSHolding(s) in Company
6th Apr 20234:17 pmRNSShare Purchase by Senior Independent NED
3rd Apr 20237:00 amRNSNew Scientific Advisory Board
28th Mar 20232:23 pmRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amRNSChange of adviser
13th Mar 20237:00 amRNSReNeuron to present at Advanced Therapies 2023
9th Mar 20234:03 pmRNSHolding(s) in Company
3rd Mar 20239:37 amRNSShare Purchase by Chief Financial Officer
1st Mar 20237:01 amRNSBlock listing application
1st Mar 20237:00 amRNSBlock Listing Review & Total Voting Rights
24th Feb 202311:20 amRNSDirector Share Purchases
15th Feb 20237:00 amRNSGrant of Options
30th Jan 20234:38 pmRNSDirector/PDMR Shareholding
27th Jan 202311:05 amRNSSecond Price Monitoring Extn
27th Jan 202311:00 amRNSPrice Monitoring Extension
24th Jan 202310:55 amRNSShare Purchase by Chief Financial Officer
23rd Jan 20233:04 pmRNSShare Purchase by Executive Chairman
19th Jan 20237:00 amRNSCompany restructuring update
3rd Jan 20237:02 amRNSTotal Voting Rights
3rd Jan 20237:00 amRNSDirectorate Change
12th Dec 20222:31 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.